YTHDF2 and bladder transitional cell carcinoma: YTHDF2 expression also varied with tumors and was a risk factor in prostate adenocarcinoma (PRAD), KICH, THCA and LIHC, and a protective factor in colon adenocarcinoma (COAD), bladder urothelial carcinoma (BLCA), LUAD, KIRC and READ.